AND
CONSIDER ADDING
Add if MRSA risk factors (see clinical considerations below)
CONSIDER ADDING
Add if MRSA risk factors (see clinical considerations below)
Signs of CAP-associated instability:
Piperacillin/tazobactam should not be used empirically as it is unnecessarily broad and may have decreased in vitro activity vs S. pneumoniae compared to ceftriaxone